Route of administration |
Baseline (ug/week)* |
Evaluation (ug/week)* |
I.v. |
|
|
Hgb < 11 g/dl (n=22) |
25.22 (23.19+27.34) |
26.76 (25.87+28.25) |
Hgb > 11 g/dl (n=56) |
21.64 (20.24+25.11) |
15.86 (14.68+16.18) |
S.c. |
|
|
Hgb < 11 g/dl (n=20) |
22.74 (21.31+24.56) |
24.81 (22.69+27.41) |
Hgb > 11 g/dl (n=45) |
21.95 (20.44+22.76) |
18.52 (16.93+19.12) |
*Geometric mean |
| Table 6: Mean (95% CI) weekly darbepoetin alfa dose requirements at baseline
an evaluation (weeks 21-24). |
